Phase III study (20050181) of panitumumab (pmab) with FOLFIRI versus FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC) pooled safety results

Peeters, Marc; WILSON, G; DUCREUX, M; VERVANTES, A; ANDRé, T; HOTKO, Y; LORDICK, F; COLLINS, S; SHING, M; PRICE, T

conference paper

oai:archive.ugent.be:431775

Phase III study (20050181) of panitumumab (pmab) with FOLFIRI versus FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC) pooled safety results

Authors: Marc Peeters
G WILSON
M DUCREUX
A VERVANTES
T ANDRé
Y HOTKO
F LORDICK
S COLLINS
M SHING
T PRICE
Publication date: 1 January 2008
Publisher
Doi

Abstract

Abstract is not available.

Similar works

Full text

Ghent University Academic Bibliography

oai:archive.ugent.be:431775

Last time updated on 12/11/2016

This paper was published in Ghent University Academic Bibliography.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.